Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia

American Journal of Hypertension

Volumn 16, Issue 5 I, 2003, Pages 393-400

  Nolan, Brian P ^a   Senechal, Patti ^a   Waqar, Sadaf ^a   Myers, Justin ^a   Standley, Cynthia A ^a   Standley, Paul R ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Hyperplasia; Hypertension; IGF 1; Nitric oxide; Rats; Vascular smooth muscle

Indexed keywords

CYCLIC GMP; HYDRAZONE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; HYPERPLASIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PULSE PRESSURE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

EID: 0038065525     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00059-1     Document Type: Article

References (29)

1. Standley PR, Ram JL, Sowers JR: The vasculature as an insulin sensitive tissue: implications of insulin and insulin-like growth factors in hypertension, diabetes, atherosclerosis and arterial smooth muscle cell growth, in Crass BF (ed): Calcium Regulating Hormones and Cardiovascular Disease. Boca Raton, CRC Press, 1994, pp 275-293.
2. Scott-Burden T, Resink TJ, Buhler RF: Growth regulation in smooth muscle cells from normal and hypertensive rats. J Cardiovasc Pharmacol 1988;12(Suppl 5):S124-S127.
3. Owens GK, Schwartz SM: Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 1982;51:280-289.
4. Hadrava V, Tremblay J, Hamet P: Intrinsic factors involved in vascular smooth muscle cell proliferation in hypertension. Clin Invest Med 1991;14(6):535-544.
5. Winer N, Weber MA, Sowers JR: The effect of antihypertensive drugs on vascular compliance. Curr Hypertens Rep 2001;3:297-304.
6. Van Gorp ADW, Van Ingen Schenau DS, Hoeks APG, Struijker Boudier HAJ, De Mey JGR, Reneman RS: In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol Heart Circ Physiol 2000;278:H1241-H1247.
7. Nava E, Llinas MT, Gonzalez JD, Salazar FJ: Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive rats. Am J Hypertens 1996;9:1236-1239.
8. Alaghband-Zadech J, Das I, Hanson MR, MacGregor CAJ, de Wardener HE, Laycock JF: Hypothalamic and plasma total nitrate/nitrite concentrations in spontaneously hypertensive rats. Exp Physiol 1996;81:881-883.
9. Kim SW, Moon KH, Lee SC, Kim NH, Kang DG, Lee JU, Choi KC, Kang YJ: Altered renal expression of nitric oxide synthase isozymes in spontaneously hypertensive rats. Korean J Intern Med 1999;14:21-26.
10. Yang H, Morton W, Lee RMKW, Kajetanowicz A, Forrest JB: Autoradiographic study of smooth muscle cell proliferation in spontaneously hypertensive rats. Clin Sci 1988;76:475-478.
11. Agrotis A, Bray PJ, Sahis J, Bobik A: Vascular smooth muscle cell proliferation in SHR and WKY: evidence for specific differences in growth inhibitory regulatory mechanisms. Clin Exp Pharmacol Physiol 1993;20:327-330.
12. Standley PR, Obards TJ, Martina CL: Cyclic stretch regulates autocrine IGF-1 in vascular smooth muscle cells: implications in vascular hyperplasia. Am J Physiol Endocrinol Metab 1999;276:E697-E705.
13. Standley PR, Stanley MA, Senechal P: Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth muscle. Am J Physiol Endocrinol Metab 2001;281:E1165-E1171.
14. Delafontaine P, Anwar A, Ku L: G-protein coupled and tyrosine kinase receptors: evidence that activation of the IGF-1 receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996;97:139-145.
15. Papapetropulos A, Marczin N, Snead MD, Cheng C, Milici A, Catravas JD: Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 1994;23:476-484.
16. Standley PR, Ram JL, Sowers JR: Insulin attenuation of vasopressin-induced calcium increases in arterial smooth muscle from Zucker rats. Endocrinology 1993;133:1693-1699.
17. +-adenosine triphosphatase regulation in hypertrophied vascular smooth muscle cells. Hypertension 1992;20:144-150.
18. Banskota NK, Taub R, Zellner K, Olsen P, King GL: Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-1. Diabetes 1989;38:123-129.
19. Bornfeldt KE, Aarnqvist HJ, Norstedt G: Regulation of insulin-like growth factor-1 gene expression by growth factors in cultured vascular smooth muscle cells. J Endocrinol 1990:125:381-386.
20. Kulik TJ, Alvardo SP: Effect of stretch on growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells. J Cell Physiol 1993;157:615-624.
21. Sowers JR, Epstein M, Frohlich E: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;34:1053-1059.
22. Freis ED, Regen D, Pillsbury H III, Mathews M: Alteration of the course of hypertension in the spontaneously hypertensive rat. Circ Res 1972:31:1-7.
23. Delafontaine P, Ku L: Reactive oxygen species stimulate IGF-1 synthesis in vascular smooth muscle cells. Cardiovasc Res 1997;33:216-222.
24. Galderisi M, Vitale G, Lupoli G, Barbieri M, Varricchio G, Carella C, de Divitiis O, Paolisso G: Inverse association between free insulin-like growth factor-1 and isovolumic relaxation in arterial systemic hypertension. Hypertension 2001;38:840-845.
25. Ren J, Sowers J, Natavio M, Brown RA. Influence of age on inotropic response to insulin and insulin-like growth factor 1 in spontaneously hypertensive rats: role of nitric oxide. Proc Soc Exp Biol Med 1999;221:46-52.
26. Inishi Y, Katoh T, Okuda T, Yamaguchi T, Kurokawa K: Modulation of renal hemodynamics by IGF-1 is absent in spontaneously hypertensive rats. Kidney Int 1997;52:165-170.
27. Vecchione C, Colella S, Fratta L, Gentile MT, Selvetella G, Frati G, Trimarco B, Lembo G: Impaired insulin-like growth factor 1 vasorelaxant effect in hypertension. Hypertension 2001;37:1480-1485.
28. Kurowska EM: Nitric oxide therapies in vascular diseases. Curr Pharm Des 2002;8:155-166.
29. Lee JU, Kang DG, Kook H: Differentially-altered vascular guanylate cyclase isoforms in experimental hypertensive rats. J Korean Med Sci 1999;14:386-392.